Shaun Day, Greatland CEO gave an upbeat presentation to over 800 London South East investors. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE
David Minchin, Helium One CEO outlines Rukwa Phase 2 at London South East live event
David Minchin, Helium One CEO outlines Rukwa Phase 2 at London South East live eventView Video
Shaun Day, Greatland CEO gave an upbeat presentation to over 800 London South East investors
Shaun Day, Greatland CEO gave an upbeat presentation to over 800 London South East investorsView Video

Latest Share Chat

AstraZeneca's COVID vaccine slightly less effective against variant found in India, CEO tells FT

Fri, 21st May 2021 21:18

May 21 (Reuters) - AstraZeneca's COVID-19 vaccine
was only slightly less effective against the variant first found
in India than the strain identified in Kent, the company's Chief
Executive Officer Pascal Soriot said in an interview with
Financial Times on Friday.

He added the company is in talks with governments, including
the United Kingdom, about new contracts for booster doses.

(Reporting by Radhika Anilkumar in Bengaluru; Editing by Chris
Reese)

Related Shares

More News

J.P.Morgan keeps AstraZeneca as 'top pick' on growth outlook, undervaluation

(Sharecast News) - AstraZeneca's growth outlook is the best in its sector and was not yet reflected in its share price, analysts at JP Morgan said following a 'deep dive' into the drug maker's financials.

21 Oct 21 11:21

Novavax shares plummet on report of further delays in Covid-19 vaccine

(Sharecast News) - Novavax's manufacturing problems may be more serious than previously thought and could hamper global efforts to fight Covid-19.

20 Oct 21 11:10

LONDON BROKER RATINGS: Upgrades for Pearson; Berenberg cuts IAG, Wizz

LONDON BROKER RATINGS: Upgrades for Pearson; Berenberg cuts IAG, Wizz

19 Oct 21 09:32

Valneva vaccine 'outperforms' AstraZeneca shot in trial

(Sharecast News) - A Covid-19 vaccine being developed by Valneva performed better than AstraZeneca's jab in trials, the French biotech announced on Monday, sending its shares soaring.

18 Oct 21 10:55

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.